Biotech

All Articles

Lykos 'remorses' certainly not making known research transgressions with publisher

.Psychopharmacology has pulled 3 short articles regarding midstage scientific trial information exam...

Analysts go into Avidity's DMD win, showing distinctions in information

.Avidity Biosciences satisfied entrepreneurs along with stage 1/2 information in Duchenne muscular d...

Actinogen's cortisol blocker neglects period 2 depression research study

.Actinogen Medical's cortisol blocker has missed out on the major endpoint of a phase 2 research stu...

Bivictrix decides going personal only method to take ADC into clinic

.Antibody-drug conjugates (ADCs) have actually gone to the facility of several a billion-dollar biob...

TPG bests up funds to $580M for financial investments across lifestyle scientific researches

.Asset manager TPG, which has supported biotechs such as Sionna Therapies as well as Santa Clam Ana ...

Merck quits phase 3 TIGIT test in bronchi cancer for futility

.Merck &amp Co.'s TIGIT course has suffered yet another obstacle. Months after shuttering a phase 3 ...

After a tough year, Exscientia folds up right into Recursion

.After a year defined through pipeline hairstyles, the departure of its own chief executive officer ...

Cullinan, after $25M package, hands back bispecific to Harbour

.Cullinan Therapeutics was actually thrilled good enough along with Port BioMed's bispecific immune ...

A more detailed look at Ferocious Biotech's Intense 15

.In this particular week's incident of "The Best Pipe," our company are actually diving right into I...

Lilly encounters phase 2 failing of tau-targeting med

.The confetti is still soaring coming from Eli Lilly's event celebrating the approval of Alzheimer's...